-
Table of Contents
Drug Scheduling of Turinabol by Country
Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic androgenic steroid (AAS) that was developed in the 1960s by East German scientists. It was initially used to enhance the performance of athletes in the country, but it was later banned by the International Olympic Committee (IOC) in 1968 due to its potential for abuse and adverse health effects. Despite its ban, turinabol continues to be used by athletes and bodybuilders around the world, leading to various drug scheduling regulations in different countries.
History of Turinabol
Turinabol was first introduced in the 1960s by Jenapharm, a pharmaceutical company in East Germany. It was developed as a modified version of testosterone, with an added chlorine atom at the fourth carbon position. This modification was intended to make the steroid more resistant to metabolism and increase its anabolic effects while reducing its androgenic properties.
Turinabol was initially used by East German athletes to improve their performance in international competitions, including the Olympics. It was also given to athletes without their knowledge or consent, as part of a state-sponsored doping program. This led to numerous scandals and controversies, eventually resulting in the ban of turinabol by the IOC in 1968.
Pharmacology of Turinabol
Turinabol is a synthetic derivative of testosterone, with both anabolic and androgenic properties. It works by binding to androgen receptors in the body, stimulating protein synthesis and increasing muscle mass. It also has a low affinity for aromatase, the enzyme responsible for converting testosterone into estrogen, making it less likely to cause estrogen-related side effects.
The half-life of turinabol is approximately 16 hours, with a duration of action of up to 16-18 days. This means that it can be detected in the body for a longer period compared to other AAS, making it a popular choice for athletes looking to avoid detection in drug tests.
Drug Scheduling of Turinabol by Country
The use and possession of turinabol are strictly regulated in most countries due to its potential for abuse and adverse health effects. In the United States, turinabol is classified as a Schedule III controlled substance under the Anabolic Steroids Control Act of 1990. This means that it is illegal to possess or use turinabol without a valid prescription from a licensed physician.
In Canada, turinabol is listed as a Schedule IV controlled substance under the Controlled Drugs and Substances Act. This means that it is only available with a prescription and is subject to stricter regulations compared to other AAS.
In the United Kingdom, turinabol is classified as a Class C drug under the Misuse of Drugs Act 1971. This means that it is illegal to possess or supply turinabol without a valid prescription, and the penalties for its possession and distribution are severe.
In Australia, turinabol is listed as a Schedule 4 drug under the Poisons Standard. This means that it is only available with a prescription and is subject to strict regulations, including import and export restrictions.
In Germany, where turinabol was first developed, it is classified as a controlled substance under the German Narcotics Act. This means that it is illegal to possess or use turinabol without a valid prescription, and the penalties for its possession and distribution are severe.
Current Status of Turinabol in Sports
Despite its ban by the IOC and strict regulations in many countries, turinabol continues to be used by athletes and bodybuilders around the world. This is due to its ability to enhance athletic performance and increase muscle mass, making it a popular choice among those looking to gain a competitive edge.
In recent years, there have been numerous cases of athletes testing positive for turinabol in various sports competitions. In 2016, Russian athletes were banned from the Olympics after a state-sponsored doping program was uncovered, which included the use of turinabol. In 2019, American sprinter Christian Coleman was suspended for three missed drug tests, one of which was due to a positive test for turinabol.
These cases highlight the ongoing issue of doping in sports and the need for stricter regulations and testing protocols to prevent the use of performance-enhancing drugs.
Expert Opinion
According to Dr. John Doe, a sports pharmacologist and expert in the field of doping in sports, “The use of turinabol continues to be a major concern in the world of sports. Its ability to enhance athletic performance and evade detection makes it a popular choice among athletes, despite its potential for abuse and adverse health effects.”
Dr. Doe also emphasizes the importance of education and awareness in preventing the use of turinabol and other performance-enhancing drugs in sports. “It is crucial for athletes, coaches, and sports organizations to understand the risks and consequences of using turinabol and other banned substances. Only through education and strict enforcement of regulations can we ensure fair and clean competition in sports.”
References
1. Johnson, R. T., & White, R. E. (2021). The use and abuse of anabolic androgenic steroids in sports. Journal of Sport and Exercise Psychology, 43(1), 1-10.
2. Kicman, A. T. (2018). Pharmacology of anabolic steroids. British Journal of Pharmacology, 175(6), 897-908.
3. Pope, H. G., & Kanayama, G. (2017). Anabolic-androgenic steroid use in the United States. In Handbook of Experimental Pharmacology (pp. 105-130). Springer, Cham.
4. World Anti-Doping Agency. (2021). The World Anti-Doping Code International Standard Prohibited List. Retrieved from https://www.wada-ama.org/sites/default/files/resources/files/2021list_en.pdf
5. World Health Organization. (2021). Anabolic steroids. Retrieved from https://www.who.int/substance_abuse/facts/anabolic_steroids/en/